InvestorsHub Logo
Followers 10
Posts 349
Boards Moderated 0
Alias Born 08/09/2011

Re: None

Monday, 10/28/2013 1:19:59 PM

Monday, October 28, 2013 1:19:59 PM

Post# of 425976
As Far as a law suit by Amarin against the FDA. If they do renege the spa. I would be suing for all the lost company and shareholder value and the 10 billion a year the indication would be worth. So say it takes them 3 more years to finally approve, and we all know Vascepa will show a benefit, 30 to 40 billion? Think that would make the national news? Then this whole stink would be out in the open. The FDA would surely be on the hot seat. I wonder if those who leaked info before the adcom would want that? IMO the reason for no nice is to avoid the legal war that would ensue. Why would the FDA want to pick this time to open a much bigger can of worms if they passed on the NCE debacle? Just ramblings from a frustrated shareholder
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News